| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/27/1995 | WO1995011239A1 Novel phenoxyalkylpiperazine derivative |
| 04/27/1995 | WO1995011238A1 Heterocyclic amines for treating ischaemic strokes |
| 04/27/1995 | WO1995011236A1 New chemopreventive compounds and a preparation method and use thereof |
| 04/27/1995 | WO1995011235A1 Pyrimidinones as antiarthritic and anti-inflammatories |
| 04/27/1995 | WO1995011233A1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 04/27/1995 | WO1995011231A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011229A1 1,11-DIESTERS OF PROSTAGLANDIN-F2α HAVING A POLAR ESTER GROUP AT C-1 |
| 04/27/1995 | WO1995011227A1 Novel spin trap nitronyl hindered phenols |
| 04/27/1995 | WO1995011221A1 Calcium receptor-active arylalkyl amines |
| 04/27/1995 | WO1995011215A1 Non-steroid androgen receptor antagonists |
| 04/27/1995 | WO1995011048A2 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO) |
| 04/27/1995 | WO1995011039A1 PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE A AND α-TOCOPHEROL |
| 04/27/1995 | WO1995011036A1 Antiviral drug |
| 04/27/1995 | WO1995011035A1 Cosmetic preparation with anti-viral action for topical application |
| 04/27/1995 | WO1995011034A1 Composition for weight reduction containing ephedrine and a mineral salt or chelate |
| 04/27/1995 | WO1995011032A1 Senna dosage form |
| 04/27/1995 | WO1995011031A1 Cerebral metabolism activator containing glucose ester derivative |
| 04/27/1995 | WO1995011030A1 Pharmaceutical formulations of aspirin and salicylates |
| 04/27/1995 | WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | WO1995011028A1 Flavin derivatives as anti-viral agents |
| 04/27/1995 | WO1995011027A1 Use of peniclorin for the treatment of posttherapeutic neuralgia |
| 04/27/1995 | WO1995011026A1 Carbostyril derivative for inhibiting production of interleukin-8 |
| 04/27/1995 | WO1995011025A1 A composition for preventing and treating kinetotia syndrome |
| 04/27/1995 | WO1995011024A1 Picosulphate dosage form |
| 04/27/1995 | WO1995011023A1 Method for the preparation of quinolone-containing oral compositions |
| 04/27/1995 | WO1995011022A1 Method for the preparation of quinolone-containing oral compositions |
| 04/27/1995 | WO1995011021A1 Use of 2-(2-alkylphenylamino)-oxazolines, -thiazolines and -imidazolines as alpha 2 adrenergic agents |
| 04/27/1995 | WO1995011020A1 2'- and/or 7- substituted taxoids |
| 04/27/1995 | WO1995011019A1 Glutamine-containing ingestible composition |
| 04/27/1995 | WO1995011018A1 Method for treating a medical patient for cardiac trauma |
| 04/27/1995 | WO1995011017A1 Ibuprofen and flurbiprofen as anti-pruritic agents |
| 04/27/1995 | WO1995011016A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof |
| 04/27/1995 | WO1995011015A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
| 04/27/1995 | WO1995011014A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | WO1995011013A2 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 04/27/1995 | WO1995011006A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 04/27/1995 | WO1995011003A1 New use of prostaglandins |
| 04/27/1995 | WO1995010999A1 Novel composition |
| 04/27/1995 | WO1995010938A1 Oligonucleotide modulation of multidrug resistance-associated protein |
| 04/27/1995 | WO1995007279A3 Process for the preparation of indolizine derivatives |
| 04/27/1995 | WO1995004533A3 Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents |
| 04/27/1995 | WO1995002409A3 Use of vitamin d and derivatives thereof for the manufacture of a medicament for protection against neuron loss |
| 04/27/1995 | WO1995002406A3 Use of benzothiophenes and benzofurans for the treatment of inflammatory bowel disease and inflammation assay method |
| 04/27/1995 | WO1994027594A3 Stable copper(i) complexes and methods related thereto |
| 04/27/1995 | DE4336642A1 Use of vanadium compounds for the production of pharmaceuticals with an antiviral action |
| 04/27/1995 | DE4336051A1 1,2-Dihydro-2-oxopyridines |
| 04/27/1995 | DE3448490C2 Verwendung von Pteridinderivaten zur Behandlung von Herzarrhythmien The use of pteridine derivatives for the treatment of cardiac arrhythmias |
| 04/27/1995 | CA2174666A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
| 04/27/1995 | CA2174655A1 New use of prostaglandins |
| 04/27/1995 | CA2174619A1 Ibuprofen and flurbiprofen as anti-pruritic agents |
| 04/27/1995 | CA2174552A1 Flavin derivatives as anti-viral agents |
| 04/27/1995 | CA2174444A1 Method for the preparation of quinolone-containing oral compositions |
| 04/27/1995 | CA2174425A1 A method for enhancing neurone survival and agents useful for same |
| 04/27/1995 | CA2174422A1 Composition for weight reduction containing ephedrine and a mineral salt or chelate |
| 04/27/1995 | CA2174350A1 2'- and/or 7- substituted taxoids |
| 04/27/1995 | CA2174241A1 1,11-diesters of prostaglandin-f2.alpha. having a polar ester group at c-1 |
| 04/27/1995 | CA2174240A1 Use of peniclorin for the treatment of posttherapeutic neuralgia |
| 04/27/1995 | CA2173468A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2173366A1 Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them |
| 04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
| 04/27/1995 | CA2171842A1 Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 04/27/1995 | CA2171332A1 Pyridazino quinoline compounds |
| 04/27/1995 | CA2170735A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/27/1995 | CA2152357A1 Cerebral metabolism activator containing glucose ester derivative |
| 04/27/1995 | CA2134179A1 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis |
| 04/26/1995 | EP0649907A1 Enzymatic hydroxylation process for the preparation of HMG-COA reductase inhibitors and intermediates thereof |
| 04/26/1995 | EP0649854A1 Bisconjugates comprising two saccharides and a spacer |
| 04/26/1995 | EP0649846A1 Galanthamine derivates, a process for their preparation and their use as medicaments |
| 04/26/1995 | EP0649839A1 Isoquinolinone-, phthalazinone-, quinazolinone- and benzotriazolinone derivatives, their preparation and their use as anti-thrombotics |
| 04/26/1995 | EP0649838A1 N-phenylalkyl/phenoxyalkyl-azetidine/pyrrozidinel piperidine/hexahydroazepine derivatives as antiarrhythmic agents |
| 04/26/1995 | EP0649662A1 Biodegradable implant precursor |
| 04/26/1995 | EP0649659A1 Rapamycin formulation for IV injection |
| 04/26/1995 | EP0649658A1 Method of tumor treatment |
| 04/26/1995 | EP0649657A1 Pharmaceutical combinations containing a NSAID and an opioid analgesic |
| 04/26/1995 | EP0649656A1 Pharmaceutical compositions based on acriflavine useful for the treatment of herpes and zona |
| 04/26/1995 | EP0649655A1 Injectable solutions containing anti-ulcer benzimidazoles and amides |
| 04/26/1995 | EP0649654A1 Use of a combination of an ACE-inhibitor with a calcium antagonist in the treatment of proteinuria |
| 04/26/1995 | EP0649651A1 Soft gelatin capsule manufacture |
| 04/26/1995 | EP0649649A2 Colloidal, dispersible formulations of active substances |
| 04/26/1995 | EP0649648A2 Skin whitening agents containing glycosides |
| 04/26/1995 | EP0649647A2 Deodorant composition |
| 04/26/1995 | EP0649602A2 Process for making soluble beet fibre |
| 04/26/1995 | EP0649467A1 Self-stabilized oligonucleotides as therapeutic agents |
| 04/26/1995 | EP0649431A1 17-AMINO SUBSTITUTED 4-AZASTEROID 5$g(a)-REDUCTASE INHIBITORS |
| 04/26/1995 | EP0649430A1 Derivatives of 16-membered ring antibiotic macrolides |
| 04/26/1995 | EP0649429A1 Heteroatomic oligonucleoside linkages |
| 04/26/1995 | EP0649425A1 Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents |
| 04/26/1995 | EP0649424A1 Dioxcyclobutene derivatives as angiotensin ii antagonists |
| 04/26/1995 | EP0649419A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them |
| 04/26/1995 | EP0649418A1 7-(2-aminoethyl)-benzothiazolones |
| 04/26/1995 | EP0649414A1 Opioid diarylmethylpiperazines and piperidines |
| 04/26/1995 | EP0649413A1 Uracil derivatives as enzyme inhibitors |
| 04/26/1995 | EP0649412A1 Pharmaceutical pyridine compounds |
| 04/26/1995 | EP0649411A1 Boronated compounds |
| 04/26/1995 | EP0649409A1 Vinyl arenas having retinoid-like activity |
| 04/26/1995 | EP0649408A1 Process for making phenylthiomethylpyridinylalkenoates |
| 04/26/1995 | EP0649407A1 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 04/26/1995 | EP0649405A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs. |
| 04/26/1995 | EP0649310A1 Stable, anticorrosive peracetic/peroxide sterilant |
| 04/26/1995 | EP0649309A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |